FDA Lifts Clinical Hold, vTv Therapeutics (VTVT) Stock Surges
Shares of vTv Therapeutics Inc. (NASDAQ: VTVT) are on a significant surge today following the lifting of a clinical hold on a key trial. As of the most recent market check, VTVT stock was soaring 64.75%, trading at $24.42. FDA Clears Cadisegliatin Clinical Program The FDA has removed the clinical hold on vTv Therapeutics’ cadisegliatin …
FDA Lifts Clinical Hold, vTv Therapeutics (VTVT) Stock Surges Read More »